| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_acdc07f88e569f63edea0306de0fbd0c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-414 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-51 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54 |
| filingDate |
2017-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_084571d9d7c1a7acadd8e7e7d8ea72af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65115b6a49fb81bae40146c6b25c0f73 |
| publicationDate |
2017-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20170115451-A |
| titleOfInvention |
Sustained release bioactive substance-carrying bone graft and manufacturing method thereof |
| abstract |
The present invention relates to a technique for binding a physiologically active substance to a bone graft through a bio-mineralization reaction which is used as a catalytic template using a genetic resource derived from a marine organism that can be used for bone regeneration, (Bone regeneration material) in which a physiologically active substance is bound to various carriers through mineralization by utilizing them. Particularly, it is possible to produce a bone graft material bearing a physiologically active substance in which release of a physiologically active substance (growth factor) is controlled in a sustained release form for 4 to 6 weeks after implantation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210130289-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200136563-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114681626-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114681626-B |
| priorityDate |
2016-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |